CN112369609A - Functional food capable of reducing uric acid and preparation method thereof - Google Patents
Functional food capable of reducing uric acid and preparation method thereof Download PDFInfo
- Publication number
- CN112369609A CN112369609A CN202011194030.2A CN202011194030A CN112369609A CN 112369609 A CN112369609 A CN 112369609A CN 202011194030 A CN202011194030 A CN 202011194030A CN 112369609 A CN112369609 A CN 112369609A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- uric acid
- functional food
- xylitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title claims abstract description 31
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 229940116269 uric acid Drugs 0.000 title claims abstract description 31
- 235000013376 functional food Nutrition 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000000843 powder Substances 0.000 claims abstract description 48
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 23
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 23
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 23
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 23
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 23
- 241000251468 Actinopterygii Species 0.000 claims abstract description 22
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 22
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 22
- 239000001508 potassium citrate Substances 0.000 claims abstract description 22
- 229960002635 potassium citrate Drugs 0.000 claims abstract description 22
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims abstract description 22
- 235000011082 potassium citrates Nutrition 0.000 claims abstract description 22
- 239000001509 sodium citrate Substances 0.000 claims abstract description 22
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 22
- 241000255789 Bombyx mori Species 0.000 claims abstract description 20
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 20
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000811 xylitol Substances 0.000 claims abstract description 20
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 20
- 229960002675 xylitol Drugs 0.000 claims abstract description 20
- 235000010447 xylitol Nutrition 0.000 claims abstract description 20
- 235000007542 Cichorium intybus Nutrition 0.000 claims abstract description 19
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 18
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 18
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 18
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 18
- 240000007087 Apium graveolens Species 0.000 claims abstract description 17
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims abstract description 17
- 235000010591 Appio Nutrition 0.000 claims abstract description 17
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 17
- 241000219784 Sophora Species 0.000 claims abstract description 17
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 17
- 235000013305 food Nutrition 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims description 24
- 241000723343 Cichorium Species 0.000 claims description 18
- 241000245665 Taraxacum Species 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 12
- 239000007779 soft material Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 241000382353 Pupa Species 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 5
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 21
- 208000002193 Pain Diseases 0.000 abstract description 11
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000003814 drug Substances 0.000 abstract description 7
- 230000036772 blood pressure Effects 0.000 abstract description 6
- 210000000232 gallbladder Anatomy 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 4
- 206010034464 Periarthritis Diseases 0.000 abstract description 3
- 206010003246 arthritis Diseases 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 2
- 238000009423 ventilation Methods 0.000 abstract description 2
- 244000298479 Cichorium intybus Species 0.000 abstract 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 208000004880 Polyuria Diseases 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 230000035619 diuresis Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000027939 micturition Effects 0.000 description 7
- 201000005569 Gout Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 239000001387 apium graveolens Substances 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108010085443 Anserine Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 241000210053 Potentilla elegans Species 0.000 description 2
- 244000046101 Sophora japonica Species 0.000 description 2
- 235000010586 Sophora japonica Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- YVWMHFYOIJMUMN-CYZWUHAYSA-N (6e,8e)-5-oxooctadeca-6,8-dienoic acid Chemical compound CCCCCCCCC\C=C\C=C\C(=O)CCCC(O)=O YVWMHFYOIJMUMN-CYZWUHAYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZMONZEBSFLINRY-UHFFFAOYSA-N COC1=C(C=CC=C1)O.[P] Chemical compound COC1=C(C=CC=C1)O.[P] ZMONZEBSFLINRY-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 206010018634 Gouty Arthritis Diseases 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010046793 Uterine inflammation Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000000617 arm Anatomy 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 210000000878 metatarsophalangeal joint Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- -1 vitamin A Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Insects & Arthropods (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
Abstract
The invention provides a functional food capable of reducing uric acid and a preparation method thereof, wherein the functional food comprises xylitol, celery seeds, angelica dahurica, sophora flower bud, dandelion, mint, moringa oleifera leaf powder, chicory, gardenia, marine fish oligopeptide, citric acid, potassium citrate, sodium citrate, silkworm chrysalis and maca powder. The product is used as a food with homology of medicine and food, has scientific ingredients, is safe and has no side effect; has rich taste and wide audience, is pressed into flaky food, and is convenient to eat and carry. The traditional Chinese medicine composition has the effects of reducing uric acid indexes, relieving ventilation symptoms, inducing diuresis to reduce edema, clearing liver and benefiting gallbladder, is beneficial to reducing blood pressure, reducing blood fat, improving immunity, and can relieve pain caused by arthritis, rheumatoid arthritis, scapulohumeral periarthritis and other inflammations.
Description
Technical Field
The invention belongs to the field of foods, and particularly relates to a functional food capable of reducing uric acid and a preparation method thereof.
Background
In recent years, with the increasing living standard and the change of dietary structure, the incidence rate of gouty arthritis is remarkably increased, and the main patients are middle-aged and old men. But the disease tends to be younger and is one of the clinically difficult diseases. At present, the mode of orally taking western medicines is mostly adopted to reduce uric acid, the gout is treated, the treatment effect is not obvious, and the Chinese medicinal composition has toxic and side effects on liver, kidney, stomach and the like of a human body, and is not suitable for long-term taking.
Therefore, a functional food which can reduce the uric acid index, relieve gout symptoms, is safe and has no toxic or side effect is needed.
Disclosure of Invention
In order to solve the problems in the background art, the invention provides a functional food capable of reducing uric acid, a preparation method thereof and a preparation method thereof.
The invention provides a functional food capable of reducing uric acid, which comprises xylitol, celery seeds, angelica dahurica, sophora flower buds, dandelion, mint, moringa oleifera leaf powder, chicory, gardenia, marine fish oligopeptide, citric acid, potassium citrate, sodium citrate, silkworm chrysalis and maca powder.
Celery seed is celery seed and contains eucalyptol, phosphorus methoxy phenol, umbelliferone, apigenin, linolenic acid, volatile oil, flavone, etc. The celery seed has the effects of dissipating qi, reducing swelling, promoting urination, dredging block, reducing blood pressure and the like, and has good curative effects on diseases such as hypertension, arthritis, rheumatoid arthritis, qi stagnation type metritis, ascites, kidney and the like.
The angelica dahurica contains volatile oil, coumarin and other substances, and has the effects of relieving exterior syndrome, dispelling cold, dispelling wind, relieving pain, dredging nasal orifice, eliminating dampness, stopping leukorrhagia, relieving swelling and expelling pus.
Flos Sophorae Immaturus is flower or flower bud of Sophora japonica of Leguminosae, and has effects of clearing heat, purging pathogenic fire, cooling blood and stopping bleeding. Modern researches find that flower buds and flowers of sophora japonica have basically the same components, mainly contain triterpenoid saponin, flavonoid, rutin, fatty acid, tannin and the like, and the rutin content is the largest in the flower buds and gradually decreases after the flowers are opened. Rutin contained in flos Sophorae Immaturus has effects of maintaining blood vessel resistance, reducing capillary permeability, relieving fragility, etc., and can be used for preventing cerebrovascular rupture for hypertension patients; the contained tannin can shorten the bleeding time and the blood coagulation time, and has stronger effect on stir-frying to yellow and stir-frying to charcoal; flos Sophorae Immaturus also has effects of lowering blood pressure, regulating blood lipid, resisting oxidation and resisting bacteria.
The herba Taraxaci contains abundant vitamins and minerals, has effects of clearing away heat and toxic materials, promoting urination, relieving diarrhea, eliminating jaundice, promoting gallbladder function, strengthening liver, and reducing cholesterol.
The mint contains menthol, and the substance can refresh breath, has various medicinal properties, can relieve abdominal pain and gallbladder problems such as spasm, and also has antiseptic, antibacterial, diuretic, expectorant, stomach invigorating and digestion promoting effects.
The moringa leaf powder is rich in nutrition and rich in elements such as calcium, potassium, iron, zinc and the like, and is a functional food containing total nutrients. The moringa leaf powder has the effects of reducing blood sugar, blood fat and blood pressure, resisting tumors, resisting oxidation, relaxing bowels, promoting urination, expelling parasites, improving sleep and the like, and can enhance the immunologic function of a human body, delay senility and prevent diseases after being eaten for a long time.
Chicory is a herb plant with homologous crude drugs and foods for years in the family of Compositae, has a strong medicinal value, and in Xinjiang Chinese herbal medicine, chicory can clear heat, promote urination, promote bile flow and diminish inflammation.
Fructus Gardeniae has effects in protecting liver, promoting function of gallbladder, lowering blood pressure, tranquilizing mind, stopping bleeding, and relieving swelling. Is used for treating icteric hepatitis, sprain, contusion, hypertension, diabetes and other diseases in traditional Chinese medicine clinic.
The marine fish oligopeptide is extracted from bonito and is rich in anserine. Anserine is a histidine dipeptide naturally existing in vertebrates, has strong water solubility and obvious functions of resisting oxidation, resisting aging, reducing uric acid and the like.
The silkworm pupa is the pupa of silkworm, and has high nutritive value and medicinal function. The silkworm pupa contains a large amount of unsaturated fatty acid and a plurality of amino acids required by human body, and also contains a plurality of vitamins such as vitamin A, B, D, trace elements such as iron, zinc, selenium and the like, and a small amount of crude fiber, chitin, antimicrobial peptide, lysozyme and polysaccharide.
The maca is rich in nutritional ingredients, contains protein, starch, dietary fiber, saccharides, fatty acid and more than 20 kinds of amino acid, and also contains various functional ingredients such as macaene, macamide, alkaloid, volatile oil, sterol and the like. Modern medical experiments prove that maca has various health-care functions of enhancing energy, resisting fatigue, improving sexual function, improving fertility, treating female climacteric syndrome and the like, and also has the effects of resisting cancer, resisting leukemia and the like.
Although eating acid, the citric acid, the potassium citrate and the sodium citrate are alkaline foods, contain rich vitamins and trace elements, are organic acids with wide application, can improve the sensory properties of foods, enhance the appetite and promote the digestion and absorption of calcium and phosphorus substances in vivo.
The pharmacology of the invention for reducing uric acid is as follows: the health-care tea is prepared from moringa leaves, mint, chicory, cape jasmine fruit and dandelion which have the effects of promoting urination and promoting urination, citric acid, potassium citrate and sodium citrate which have the effects of neutralizing uric acid and regulating electrolyte balance of a human body, celery seeds, angelica dahurica and sophora flower buds which have the effects of relieving pain caused by uric acid crystallization, marine fish oligopeptide, maca powder and silkworm chrysalis which have the effects of quickly removing free radicals, resisting fatigue and protecting kidneys. The multiple components are matched with each other, and the effects of reducing uric acid indexes, dissolving crystal, removing calculus and relieving gout symptoms are achieved.
Preferably, the formula comprises the following components in parts by weight: 5-30 parts of xylitol, 10-40 parts of celery seeds, 5-30 parts of angelica dahurica, 5-18 parts of sophora flower bud, 5-20 parts of dandelion, 5-20 parts of mint, 3-18 parts of moringa oleifera leaf powder, 5-40 parts of chicory, 10-40 parts of gardenia, 2-30 parts of marine fish oligopeptide, 2-15 parts of citric acid, 1-10 parts of potassium citrate, 1-10 parts of sodium citrate, 1-10 parts of silkworm chrysalis and 1-10 parts of maca powder.
Particularly preferably, the formula comprises the following components in parts by weight: 30 parts of xylitol, 40 parts of celery seeds, 15 parts of angelica dahurica, 8 parts of sophora flower buds, 5 parts of dandelion, 5 parts of mint, 5 parts of moringa oleifera leaf powder, 40 parts of chicory, 40 parts of gardenia, 3 parts of marine fish oligopeptide, 2 parts of citric acid, 2 parts of potassium citrate, 2 parts of sodium citrate, 4 parts of silkworm chrysalis and 5 parts of maca powder.
Particularly preferably, the formula comprises the following components in parts by weight: 5 parts of xylitol, 25 parts of celery seeds, 10 parts of angelica dahurica, 10 parts of sophora flower buds, 15 parts of dandelion, 10 parts of mint, 8 parts of moringa oleifera leaf powder, 20 parts of chicory, 20 parts of gardenia, 5 parts of marine fish oligopeptide, 5 parts of citric acid, 1 part of potassium citrate, 1 part of sodium citrate, 2 parts of silkworm chrysalis and 3 parts of maca powder.
Particularly preferably, the formula comprises the following components in parts by weight: 7 parts of xylitol, 17 parts of celery seeds, 5 parts of angelica dahurica, 7 parts of sophora flower buds, 10 parts of dandelion, 8 parts of mint, 7 parts of moringa oleifera leaf powder, 15 parts of chicory, 15 parts of gardenia, 3 parts of marine fish oligopeptide, 2 parts of citric acid, 1 part of potassium citrate, 1 part of sodium citrate, 2 parts of silkworm chrysalis and 2 parts of maca powder.
The invention also provides a preparation method of the functional food capable of reducing uric acid, which comprises the following steps:
(1) preparing materials: weighing various raw materials according to the formula amount respectively;
(2) crushing: respectively pulverizing xylitol, semen Apii graveolentis, radix Angelicae Dahuricae, flos Sophorae Immaturus, herba Taraxaci, herba Menthae, herba Cichorii, fructus Gardeniae, and pupa Bombycis, sieving with 40-100 mesh sieve, and mixing to obtain pulverized raw materials;
(3) preparing materials: adding moringa oleifera leaf powder, ocean fish oligopeptide powder, maca powder, citric acid, potassium citrate and sodium citrate into the crushed raw materials to obtain a mixed raw material;
(4) preparing a soft material: pouring the mixed raw materials into a trough type mixer, uniformly mixing, adding 40-75% ethanol accounting for 10-20% of the weight of the mixed raw materials under the stirring state of the trough type mixer, and uniformly stirring to obtain a soft material;
(5) and (3) granulating: pouring the prepared soft material into a swing granulator for swing granulation, and sieving with a 20-mesh sieve to obtain granules;
(6) and (3) drying: drying the granules at 40-65 ℃ until the moisture content is less than 5%;
(7) tabletting: and tabletting the dried granules into food by a tabletting machine.
The invention has the following beneficial effects:
the product is used as a food with homology of medicine and food, has scientific ingredients, is safe and has no toxic or side effect; has rich taste and wide audience, is pressed into flaky food, and is convenient to eat and carry. The product can reduce uric acid index, relieve ventilation symptom, promote urination, relieve swelling, clear liver and promote gallbladder, is helpful for lowering blood pressure, reducing blood lipid, improving immunity, and relieving pain caused by arthritis, rheumatoid diseases, scapulohumeral periarthritis, etc.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below. It is to be understood that the described embodiments are merely exemplary of the invention, and not restrictive of the full scope of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
A functional food capable of reducing uric acid comprises the following components in parts by mass: 5 parts of xylitol, 10 parts of celery seeds, 5 parts of angelica dahurica, 5 parts of sophora flower buds, 5 parts of dandelion, 5 parts of mint, 3 parts of moringa oleifera leaf powder, 5 parts of chicory, 10 parts of gardenia, 2 parts of marine fish oligopeptide, 2 parts of citric acid, 1 part of potassium citrate, 1 part of sodium citrate, 1 part of silkworm chrysalis and 1 part of maca powder.
Example 2
A functional food capable of reducing uric acid comprises the following components in parts by mass: 30 parts of xylitol, 40 parts of celery seeds, 30 parts of angelica dahurica, 18 parts of sophora flower buds, 20 parts of dandelion, 20 parts of mint, 18 parts of moringa oleifera leaf powder, 40 parts of chicory, 40 parts of gardenia, 30 parts of marine fish oligopeptide, 15 parts of citric acid, 10 parts of potassium citrate, 10 parts of sodium citrate, 10 parts of silkworm chrysalis and 10 parts of maca powder.
Example 3
A functional food capable of reducing uric acid comprises the following components in parts by mass: 30 parts of xylitol, 40 parts of celery seeds, 15 parts of angelica dahurica, 8 parts of sophora flower buds, 5 parts of dandelion, 5 parts of mint, 5 parts of moringa oleifera leaf powder, 40 parts of chicory, 40 parts of gardenia, 3 parts of marine fish oligopeptide, 2 parts of citric acid, 2 parts of potassium citrate, 2 parts of sodium citrate, 4 parts of silkworm chrysalis and 5 parts of maca powder.
Example 4
A functional food capable of reducing uric acid comprises the following components in parts by mass: 5 parts of xylitol, 25 parts of celery seeds, 10 parts of angelica dahurica, 10 parts of sophora flower buds, 15 parts of dandelion, 10 parts of mint, 8 parts of moringa oleifera leaf powder, 20 parts of chicory, 20 parts of gardenia, 5 parts of marine fish oligopeptide, 5 parts of citric acid, 1 part of potassium citrate, 1 part of sodium citrate, 2 parts of silkworm chrysalis and 3 parts of maca powder.
Example 5
A functional food capable of reducing uric acid comprises the following components in parts by mass: 7 parts of xylitol, 17 parts of celery seeds, 5 parts of angelica dahurica, 7 parts of sophora flower buds, 10 parts of dandelion, 8 parts of mint, 7 parts of moringa oleifera leaf powder, 15 parts of chicory, 15 parts of gardenia, 3 parts of marine fish oligopeptide, 2 parts of citric acid, 1 part of potassium citrate, 1 part of sodium citrate, 2 parts of silkworm chrysalis and 2 parts of maca powder.
Example 6
A preparation method of functional food capable of reducing uric acid comprises the following steps:
(1) preparing materials: weighing various raw materials according to the formula amount respectively;
(2) crushing: respectively pulverizing xylitol, semen Apii Graveolentis, radix Angelicae Dahuricae, flos Sophorae Immaturus, herba Taraxaci, herba Menthae, herba Cichorii, fructus Gardeniae, and pupa Bombycis to 40 mesh by pulverizer to obtain pulverized raw materials;
(3) preparing materials: adding moringa oleifera leaf powder, ocean fish oligopeptide powder, maca powder, citric acid, potassium citrate and sodium citrate into the crushed raw materials to obtain a mixed raw material;
(4) preparing a soft material: pouring the mixed raw materials into a trough type mixer, uniformly mixing, adding 75% ethanol accounting for 10% of the weight of the mixed raw materials under the stirring state of the trough type mixer, and uniformly stirring to obtain a soft material;
(5) and (3) granulating: pouring the prepared soft material into a swing granulator for swing granulation, and sieving with a 20-mesh sieve to obtain granules;
(6) and (3) drying: drying the granules at 40 ℃ until the water content is 3.8%;
(7) tabletting: and tabletting the dried granules into food by a tabletting machine.
Example 7
A preparation method of functional food capable of reducing uric acid comprises the following steps:
(1) preparing materials: weighing various raw materials according to the formula amount respectively;
(2) crushing: respectively pulverizing xylitol, semen Apii Graveolentis, radix Angelicae Dahuricae, flos Sophorae Immaturus, herba Taraxaci, herba Menthae, herba Cichorii, fructus Gardeniae, and pupa Bombycis to 100 mesh by pulverizer to obtain pulverized raw materials;
(3) preparing materials: adding moringa oleifera leaf powder, ocean fish oligopeptide powder, maca powder, citric acid, potassium citrate and sodium citrate into the crushed raw materials to obtain a mixed raw material;
(4) preparing a soft material: pouring the mixed raw materials into a trough type mixer, uniformly mixing, adding 40% ethanol accounting for 20% of the weight of the mixed raw materials under the stirring state of the trough type mixer, and uniformly stirring to obtain a soft material;
(5) and (3) granulating: pouring the prepared soft material into a swing granulator for swing granulation, and sieving with a 20-mesh sieve to obtain granules;
(6) and (3) drying: drying the granules at 65 ℃ until the water content is 3.5%;
(7) tabletting: and tabletting the dried granules into food by a tabletting machine.
The curative effect of the embodiment of the application is as follows:
case 1: for men, 42 years old, Yunnan Kunming people, patients have repeated red swelling and pain of the bare joints of the right feet, hyperuricemia and gout are diagnosed by hospitals, and then the pain is relieved but is repeatedly attacked by western medicines. After the product is taken for 15 days, the pain is relieved, after the product is taken for 2 months, the disease condition is gradually relieved and improved, and the blood uric acid level is reduced from 585 mu mol/L to 315 mu mol/L.
Case 2: women, 57 years old, Hunan, have gout for many years, and the metatarsophalangeal joints, arms, and finger joints are often painful, swollen, red, deformed, and associated with severe pain. Some anti-inflammatory and analgesic medicines are taken, the disease condition is relieved, but the disease recurs after a little carelessness of diet, and the pain is caused. After the product of the invention is taken for 2 months, the symptoms are obviously improved, the pain recurrence time interval is longer and longer, and the blood uric acid level is also reduced from 635 mu mol/L to 345 mu mol/L.
Case 3: male, 46 years old, gansu lanzhou, white collar of office, slightly obese, had scapulohumeral periarthritis and slight fatty liver, were not treated with drugs. After the product of the invention is taken for 1 half and a half, the pain of the shoulder and the neck is obviously relieved, the fatty liver is gradually improved, the immunity is improved, and the whole people have much energy.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (6)
1. A functional food capable of reducing uric acid, which is characterized in that: comprises xylitol, celery seeds, angelica dahurica, sophora flower bud, dandelion, mint, moringa oleifera leaf powder, chicory, gardenia, marine fish oligopeptide, citric acid, potassium citrate, sodium citrate, silkworm chrysalis and maca powder.
2. The functional food for reducing uric acid according to claim 1, wherein: the formula comprises the following components in parts by mass: 5-30 parts of xylitol, 10-40 parts of celery seeds, 5-30 parts of angelica dahurica, 5-18 parts of sophora flower bud, 5-20 parts of dandelion, 5-20 parts of mint, 3-18 parts of moringa oleifera leaf powder, 5-40 parts of chicory, 10-40 parts of gardenia, 2-30 parts of marine fish oligopeptide, 2-15 parts of citric acid, 1-10 parts of potassium citrate, 1-10 parts of sodium citrate, 1-10 parts of silkworm chrysalis and 1-10 parts of maca powder.
3. The functional food capable of reducing uric acid according to claim 1 or 2, characterized in that: the formula comprises the following components in parts by mass: 30 parts of xylitol, 40 parts of celery seeds, 15 parts of angelica dahurica, 8 parts of sophora flower buds, 5 parts of dandelion, 5 parts of mint, 5 parts of moringa oleifera leaf powder, 40 parts of chicory, 40 parts of gardenia, 3 parts of marine fish oligopeptide, 2 parts of citric acid, 2 parts of potassium citrate, 2 parts of sodium citrate, 4 parts of silkworm chrysalis and 5 parts of maca powder.
4. The functional food capable of reducing uric acid according to claim 1 or 2, characterized in that: the formula comprises the following components in parts by mass: 5 parts of xylitol, 25 parts of celery seeds, 10 parts of angelica dahurica, 10 parts of sophora flower buds, 15 parts of dandelion, 10 parts of mint, 8 parts of moringa oleifera leaf powder, 20 parts of chicory, 20 parts of gardenia, 5 parts of marine fish oligopeptide, 5 parts of citric acid, 1 part of potassium citrate, 1 part of sodium citrate, 2 parts of silkworm chrysalis and 3 parts of maca powder.
5. The functional food capable of reducing uric acid according to claim 1 or 2, characterized in that: the formula comprises the following components in parts by mass: 7 parts of xylitol, 17 parts of celery seeds, 5 parts of angelica dahurica, 7 parts of sophora flower buds, 10 parts of dandelion, 8 parts of mint, 7 parts of moringa oleifera leaf powder, 15 parts of chicory, 15 parts of gardenia, 3 parts of marine fish oligopeptide, 2 parts of citric acid, 1 part of potassium citrate, 1 part of sodium citrate, 2 parts of silkworm chrysalis and 2 parts of maca powder.
6. A method for preparing a functional food capable of lowering uric acid according to any one of claims 1 to 5, characterized by: the method comprises the following steps:
(1) preparing materials: weighing various raw materials according to the formula amount respectively;
(2) crushing: pulverizing xylitol, semen Apii Graveolentis, radix Angelicae Dahuricae, flos Sophorae Immaturus, herba Taraxaci, herba Menthae, herba Cichorii, fructus Gardeniae, and pupa Bombycis into 40-100 mesh powder, and mixing to obtain pulverized raw materials;
(3) preparing materials: adding moringa oleifera leaf powder, ocean fish oligopeptide powder, maca powder, citric acid, potassium citrate and sodium citrate into the crushed raw materials to obtain a mixed raw material;
(4) preparing a soft material: pouring the mixed raw materials into a trough type mixer, uniformly mixing, adding 40-75% ethanol accounting for 10-20% of the weight of the mixed raw materials under the stirring state of the trough type mixer, and uniformly stirring to obtain a soft material;
(5) and (3) granulating: pouring the prepared soft material into a swing granulator for swing granulation, and sieving with a 20-mesh sieve to obtain granules;
(6) and (3) drying: drying the granules at 40-65 ℃ until the moisture content is less than 5%;
(7) tabletting: and tabletting the dried granules into food by a tabletting machine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011194030.2A CN112369609A (en) | 2020-10-30 | 2020-10-30 | Functional food capable of reducing uric acid and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011194030.2A CN112369609A (en) | 2020-10-30 | 2020-10-30 | Functional food capable of reducing uric acid and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112369609A true CN112369609A (en) | 2021-02-19 |
Family
ID=74576067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011194030.2A Pending CN112369609A (en) | 2020-10-30 | 2020-10-30 | Functional food capable of reducing uric acid and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112369609A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112986228A (en) * | 2021-03-01 | 2021-06-18 | 杭州可靠护理用品股份有限公司 | Hydrogel with uric acid detection function and application thereof in disposable nursing product |
| CN114099620A (en) * | 2021-11-10 | 2022-03-01 | 四川中昶康旅实业发展有限公司 | Selenium wine for protecting liver and preventing liver diseases |
| CN114947124A (en) * | 2022-04-22 | 2022-08-30 | 北京恒生药业有限公司 | Solid composition with gout relieving effect and preparation method thereof |
| CN115299602A (en) * | 2022-06-29 | 2022-11-08 | 北京彩晔健康管理有限公司 | Uric acid reducing composition and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109511984A (en) * | 2019-01-09 | 2019-03-26 | 丁强 | A kind of special dietary seafood with the alleviation gout that celery seed, potassium citrate etc. are primary raw material preparation |
| CN110038119A (en) * | 2019-04-28 | 2019-07-23 | 杭州泽健医药科技有限公司 | A kind of pharmaceutical composition with anti-trioxypurine and antifatigue effect |
-
2020
- 2020-10-30 CN CN202011194030.2A patent/CN112369609A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109511984A (en) * | 2019-01-09 | 2019-03-26 | 丁强 | A kind of special dietary seafood with the alleviation gout that celery seed, potassium citrate etc. are primary raw material preparation |
| CN110038119A (en) * | 2019-04-28 | 2019-07-23 | 杭州泽健医药科技有限公司 | A kind of pharmaceutical composition with anti-trioxypurine and antifatigue effect |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112986228A (en) * | 2021-03-01 | 2021-06-18 | 杭州可靠护理用品股份有限公司 | Hydrogel with uric acid detection function and application thereof in disposable nursing product |
| CN112986228B (en) * | 2021-03-01 | 2023-08-29 | 杭州可靠护理用品股份有限公司 | Hydrogel with uric acid detection function and application of hydrogel to disposable nursing products |
| CN114099620A (en) * | 2021-11-10 | 2022-03-01 | 四川中昶康旅实业发展有限公司 | Selenium wine for protecting liver and preventing liver diseases |
| CN114947124A (en) * | 2022-04-22 | 2022-08-30 | 北京恒生药业有限公司 | Solid composition with gout relieving effect and preparation method thereof |
| CN115299602A (en) * | 2022-06-29 | 2022-11-08 | 北京彩晔健康管理有限公司 | Uric acid reducing composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112369609A (en) | Functional food capable of reducing uric acid and preparation method thereof | |
| Kulkarni et al. | Indian gooseberry (Emblica officinalis): Complete pharmacognosy review | |
| CN104873763A (en) | Health-care product for conditioning Qi deficiency constitution | |
| CN103520497A (en) | Chinese medicinal composition for treating gout and preparation method thereof | |
| WO2016202183A1 (en) | Formula dog food and preparation method therefor | |
| CN104873826A (en) | Tea drink capable of clearing away lung heat and dispelling damp and preparation method thereof | |
| CN103977206A (en) | Traditional Chinese medicine preparation capable of improving gastrointestinal digestive function and production method thereof | |
| CN103947807B (en) | A kind of preparation method of heat-clearing and detoxifying herbal tea | |
| CN104606663B (en) | A kind of Chinese medicine for promoting Recovery and preparation method thereof | |
| CN105597057A (en) | Method for preparing traditional Chinese medicine composition powder for treating acute nephritis | |
| CN106177634A (en) | A kind of weight-reducing compound preparation and preparation method thereof | |
| CN102178870B (en) | Chinese medicinal preparation for promoting qi circulation, promoting blood circulation, softening hard mass and eliminating stagnation for people with qi-depression and phlegm-damp physique, preparation method thereof and application thereof | |
| CN105125789A (en) | Spleen and stomach strengthening preparation for treating stomachache and preparation method of preparation | |
| CN101524495A (en) | Chinese medicinal compound preparation for treating diarrhea and preparation method thereof | |
| CN104258165A (en) | Pharmaceutical preparation for preventing loach from hemorrhagic disease | |
| CN103585509A (en) | Compound collina traditional Chinese medicine oral liquid and preparation method thereof | |
| CN107737250A (en) | A kind of hypertension Chinese medicine composition and preparation method thereof | |
| CN101810661B (en) | Chinese medicament for curing gastropathy | |
| CN103656507B (en) | Urge pregnant Chinese medicine prescription and preparation method follicular phase | |
| CN105412875A (en) | Traditional Chinese medicine composition for treating dyspepsia of children | |
| CN106728199B (en) | Application of traditional Chinese medicine composition in preparation of medicine for improving fresh and fragrant flavor quality of aquatic products | |
| CN113142573A (en) | Sugar-reducing, lipid-lowering and blood-viscosity purely natural plant tablet candy and preparation method thereof | |
| CN104706866A (en) | Traditional Chinese medicine preparation for treating enteritis and preparation method of traditional Chinese medicine preparation | |
| CN105062820A (en) | Summer herbal body-building wine and preparation method thereof | |
| Mishra | An Analysis of Health Benefits of Bitter Melon |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210219 |
|
| RJ01 | Rejection of invention patent application after publication |